14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.23 $7.87 Thursday, 2nd May 2024 ARDX stock ended at $6.79. This is 2.72% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 4.75% from a day low at $6.53 to a day high of $6.84.
90 days $6.23 $10.13
52 weeks $3.16 $10.13

Historical Ardelyx prices

Date Open High Low Close Volume
Mar 29, 2023 $4.27 $4.72 $4.26 $4.68 10 447 032
Mar 28, 2023 $4.31 $4.47 $4.15 $4.22 6 666 718
Mar 27, 2023 $4.03 $4.42 $4.01 $4.32 14 471 145
Mar 24, 2023 $4.03 $4.07 $3.90 $4.00 4 426 164
Mar 23, 2023 $4.01 $4.23 $3.94 $4.06 6 645 699
Mar 22, 2023 $4.11 $4.13 $3.90 $3.92 5 721 811
Mar 21, 2023 $3.90 $4.22 $3.89 $4.14 7 797 290
Mar 20, 2023 $4.05 $4.06 $3.77 $3.88 7 461 998
Mar 17, 2023 $3.99 $4.08 $3.87 $4.05 29 057 498
Mar 16, 2023 $3.97 $4.15 $3.92 $4.03 5 976 445
Mar 15, 2023 $3.87 $4.01 $3.83 $3.99 7 436 575
Mar 14, 2023 $3.76 $3.97 $3.76 $3.95 7 821 129
Mar 13, 2023 $3.51 $3.85 $3.48 $3.73 10 058 509
Mar 10, 2023 $3.83 $3.83 $3.48 $3.56 8 952 969
Mar 09, 2023 $4.09 $4.14 $3.79 $3.82 7 149 012
Mar 08, 2023 $3.90 $4.11 $3.82 $4.07 6 127 136
Mar 07, 2023 $4.04 $4.09 $3.92 $3.94 9 886 884
Mar 06, 2023 $3.83 $4.16 $3.81 $3.90 15 036 809
Mar 03, 2023 $3.40 $3.98 $3.39 $3.82 53 058 307
Mar 02, 2023 $2.90 $2.96 $2.82 $2.89 6 055 293
Mar 01, 2023 $2.91 $3.01 $2.90 $2.92 4 979 242
Feb 28, 2023 $2.89 $2.96 $2.87 $2.88 7 548 564
Feb 27, 2023 $2.97 $3.04 $2.85 $2.87 5 103 399
Feb 24, 2023 $3.05 $3.10 $2.93 $2.95 3 413 143
Feb 23, 2023 $2.99 $3.09 $2.98 $3.07 5 037 052
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT